Insulinska rezistencija je stanje udruženo sa genetskom predispozicijom, sedantarnim načinom života i starenjem. Ono je izazvano i podstaknuto gojaznošću. Metabolički sindrom (MS) pak, predstavlja koincidentno postojanje više metaboličkih poremećaja u čijoj se osnovi nalazi insulinska rezistencija. Cilj ovog rada je bio da se utvrde antropometrijske mere kod obolelih od akutnog infarkta miokarda (AIM) sa i bez metaboličkog sindroma. Prospektivnom studijom obuhvaćeno je 77 bolesnika oba pola koji su lečeni zbog AIM u koronarnoj jedinici Interne klinike-Laplje selo KBC-a Priština sa sedištem u Gračanici. Bolesnici sa reinfarktom miokarda nisu uključivani u istraživanje. Od ukupno 77 ispitanika sa AIM 44 ispitanika je imalo MS ili 57,1% dok je 33 ispitanika bilo bez MS, ili 42.9%. Naše istraživanje je pokazalo sledeće: učestalost MS kod ispitanika lečenih zbog AIM je bila 57,1%; u odnosu na polnu zastupljenost nije nađena bitna razlika između ispitanika sa AIM sa i bez MS ; u grupi ispitanika sa AIM i MS muškarci su bili zastupljeniji (63,6%) u odnosu na žene; nije nađena bitna razlika između poređenih grupa ispitanika u odnosu na starosnu zastupljenost ; poređenjem telesne visine i težine između ispitanika sa AIM sa i bez MS nije nađena značajna razlika ; dobijena je bitna razlika između poređenih grupa ispitanika u odnosu na indeks telesne mase-BMI. Prosečna vrednost BMI kod ispitanika sa AIM i MS je bila 29,34 kg/m2.
Stokić EJ, Srdić B, Peter A, Ivković-Lazar TA. Masna masa tela u normalnoj uhranjenosti. Medicinski pregled. 2002;55(9–10):407–11.
2.
Initiative NHLBIOE. Summary report: Strategy development workshop for public education on weight and obesity. 1994.
3.
Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280(21):1843–8.
4.
Ridker P, Genest J, Libby P. Risk factors for atherosclerotic disease. In: Heart disease: A textbook of cardiovascular medicine. 2001. p. 1010–39.
5.
Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. American Journal of Epidemiology. 1995;141(12):1117–27.
6.
Rosengren A, Wedel H, Wilhelmsen L. Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. European Heart Journal. 1999;20(4):269–77.
7.
Saltzler CC, Mayer J. Simple criterion of obesity. Postgraduate Medicine. 1965;38:101–7.
8.
Seidell JC, Bakker CJ, Kooy K. Imaging techniques for measuring adipose-tissue distribution: A comparison between computed tomography and 1.5-T magnetic resonance. American Journal of Clinical Nutrition. 1990;51(6):953–7.
9.
Sjostrom L. The sagittal diameter is valid marker of visceral adipose tissue. International Journal of Obesity. 1994;18(2):46–52.
10.
Milenković S. Primarna prevencija ishemijske bolesti srca. 1993.
11.
Stolić R. Socijalno-medicinski aspekti gojaznosti. In: Komorbiditeti gojaznosti i neka odabrana poglavlja. 2010. p. 50–60.
12.
Stone NJ. Diet, nutritional issues, and obesity. In: Textbook of cardiovascular medicine. 2002. p. 15–41.
13.
Stožinić SP. Infarkt miokarda. 1991.
14.
Varady PD, Maxwell MH. Assessment of statistically significant changes in diastolic blood pressures. JAMA. 1972;221(4):365–8.
15.
Vukotić M. Osnovne karakteristike nekih pokazatelja studiranih populacija po regionima sa posebnim osvrtom na faktore rizika. In: Kardiovaskularna oboljenja – epidemiologija i prevencija. 1991. p. 92–7.
16.
Wenzel H, Wechsler JG, Schimming H, Ditschuneit H. Determination of body density by weighing and measuring gas-free body volume. In: Obesity in Europe. 1993. p. 101–5.
17.
Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, et al. Weight, weight change, and coronary heart disease in women: Risk within the “normal” weight range. JAMA. 1995;273(6):461–5.
18.
Zoccali C. The obesity epidemics in ESRD: from wasting to waist? Nephrology. Dialysis, Transplantation. 2009;24(2):376–80.
Obesity: Preventing and managing the global epidemic. Report of a WHO. In: Consultation on Obesity. 1997. p. 9–12.
21.
Armelini F, Bosello O, Zamboni M, Rigo L. Real time sonography in the determination of visceral adipose tissue. International Journal of Obesity. 1989;13:73–6.
22.
Bray GA. The obese patient, major problem. Internal Medicine. 1976;9(450):1.
23.
Bray GA. Pathophysiology of obesity. American Journal of Clinical Nutrition. 1992;55(2 Suppl):488–94.
24.
Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. Journal of Clinical Investigation. 2003;111(9):1409–21.
25.
Čutović M, Borkovački R. Gojaznost i zaštita od kardiovaskularnih oboljenja. In: Kardiologija. 1994. p. 194–208.
26.
Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III. 2001;285(19):2486–97.
27.
Heber D, Ingles S, Ashley JM, Maxwell MH, Lyons RF, Elashoff RM. Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. American Journal of Clinical Nutrition. 1996;64(3 Suppl):472–7.
28.
Metropoliten life insurance company: New weight standards for men and women. Statistical Bulletin. 1959;40:1–4.
29.
Ivković-Lazar T. Značaj egzaktnog određivanja veličine i specifične distribucije masnog tkiva u svetlu metaboličkog sindroma. In: Praktični i bazični problemi dijabetologije i bolesti metabolizma - Inovacije znanja XI. 2005. p. 24–30.
30.
Jensen LB, Quaade F. Abdominal sagittal diameter as indicator of somatic risk obesity. International Journal of Obesity. 1995;19(2):94–5.
31.
Kahn HS, Austin H, Williamson DF. Anthropometric index for estimating the risk of ischemic heart disease: Opportunities for clinical application. Circulation. 1993;88(4):451–61.
32.
Kovačević M. Faktori rizika - savremeno shvatanje o njihovom značaju. In: Koronarna bolest. 1981. p. 23–6.
33.
Krotkiewski M, Bjornttorp P, Sjostrom L. Regional variation of fat cell size in young, middle-aged and obese women. In: Recent Advances in Obesity. 1975. p. 230–6.
34.
Kushner RF, Kunigk A, Alspaugh M, Andronis PT, Leitch CA, Schoeller DA. Validation of bioelectrical-impedance analysis as a measurement of change in body composition in obesity. American Journal of Clinical Nutrition. 1990;52(2):219–23.
35.
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et al. A prospective study of obesity and risk of coronary heart disease in women. New England Journal of Medicine. 1990;322(13):882–9.
36.
Milenković S. Prevencija vodećih bolesti kardiovaskularnog sistema - arterijske hipertenzije, ateroskleroze i ishemijske bolesti srca. Prishtinë: Zavod za udžbenike i nastavna sredstva Kosova. 1990;
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
